iiinova — where your digital self keeps evolving

Reposted by Sebastian Klobuch

Jon Lim, FRCP PhD @drjonlim.bsky.social · 03/02/2026

👉...cutting-edge science, clinical insights & discussions re: real-world implementation of TIL therapy. Featuring keynote speakers: Inge Marie Svane 🇩🇰 & Sebastian Klobuch 🇳🇱. @sklobuch.bsky.social @debrajosephs.bsky.social @turajliclab.bsky.social @beckilee.bsky.social

043

Reposted by Sebastian Klobuch

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/10/2025

Beyond immune checkpoint blockade: what’s next for #melanoma? At #ESMO25, explore: 📌 Why move beyond ICB 📌 #AdoptiveCellTherapy 📌 Treating unresectable stage IV melanoma 📌 Bispecific T-cell engagers 📅 17 Oct | 14:00–15:30 🔗 buff.ly/RaDTAFV

052

Reposted by Sebastian Klobuch

ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/04/2025

🚀 ESMO is now on Bluesky This is not an April Fools' announcement, nor is it an AI-generated post. ESMO is launching on Bluesky with a poll on AI to start the conversation. Join us for the latest in oncology education and information. #AIOncology #HealthAI #ESMOAI25

32511

Reposted by Sebastian Klobuch

Jon Lim, FRCP PhD @drjonlim.bsky.social · 04/01/2025

📚 Our review on the management of toxicities of cell therapy for solid cancers is now out in print in #ESMO ‘s flagship IO journal ESMO IOTECH. 👉 incl. TILs, TCR-T & CAR-T + associated tx e.g. IL-2 & NMA-LD. 🔗 www.esmoiotech.org/article/S259... @sophiawongyn.bsky.social @fbmh-uom.bsky.social

🔗 https://www.esmoiotech.org/article/S2590-0188(24)00034-0/fulltext

0114

Reposted by Sebastian Klobuch

Sophia Wong @sophiawongyn.bsky.social · 07/12/2024

Let’s go! 🙌🏼🙌🏼🙌🏼 #CellTherapy #TILTherapy Welcome to 🦋🦋🦋 @drbetofmdphd.bsky.social @sklobuch.bsky.social

052

Reposted by Sebastian Klobuch

Jon Lim, FRCP PhD @drjonlim.bsky.social · 07/12/2024

Yay 🙌! Our #CellTherapy for solid cancers community is growing here 🦋. Welcome 👋 @drbetofmdphd.bsky.social 🇺🇸 @sklobuch.bsky.social 🇳🇱 @sophiawongyn.bsky.social 🇸🇬 #CancerImmunotherapy

072